These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 1606091)
1. Severe autoimmune hemolytic anemia in two patients treated with fludarabine for chronic lymphocytic leukemia. Bastion Y; Coiffier B; Dumontet C; Espinouse D; Bryon PA Ann Oncol; 1992 Feb; 3(2):171-2. PubMed ID: 1606091 [No Abstract] [Full Text] [Related]
2. Severe autoimmune hemolytic anemia in a patient with chronic lymphocytic leukemia responsive to fludarabine-based treatment. Tosti S; Caruso R; D'Adamo F; Picardi A; Ali Ege M; Girelli G; Mauro FR; Maurillo L; Amadori S Ann Hematol; 1992 Nov; 65(5):238-9. PubMed ID: 1457584 [No Abstract] [Full Text] [Related]
3. Severe autoimmune hemolytic anemia following fludarabine therapy in a patient with chronic lymphocytic leukemia. Tsiara S; Christou L; Konstantinidou P; Panteli A; Briasoulis E; Bourantas KL Am J Hematol; 1997 Apr; 54(4):342. PubMed ID: 9092698 [No Abstract] [Full Text] [Related]
10. Evan's syndrome precipitated by fludarabine therapy in a case of CLL. Sen K; Kalaycio M Am J Hematol; 1999 Jul; 61(3):219. PubMed ID: 10398320 [No Abstract] [Full Text] [Related]
11. Severe autoimmune hemolytic anemia in eight patients treated with fludarabine. Gonzalez H; Leblond V; Azar N; Sutton L; Gabarre J; Binet JL; Vernant JP; Dighiero G Hematol Cell Ther; 1998 Jun; 40(3):113-8. PubMed ID: 9698219 [TBL] [Abstract][Full Text] [Related]
12. Fludarabine-induced autoimmune hemolytic anemia in a CLL patient: rituximab as the treatment of choice? Smolej L Leuk Res; 2007 Feb; 31(2):267; author reply 268-9. PubMed ID: 16716397 [No Abstract] [Full Text] [Related]
13. Successful reduced-intensity allogeneic transplantation utilizing a fludarabine-based preparative regimen in a patient with chronic lymphocytic leukaemia and a history of fludarabine-associated autoimmune haemolytic anaemia. Ford CD; Asch J; Pulsipher M; Petersen FB Br J Haematol; 2004 Aug; 126(4):623-4. PubMed ID: 15287959 [No Abstract] [Full Text] [Related]
14. Mixed-type autoimmune hemolytic anemia following fludarabine treatment in a patient with chronic lymphocytic leukemia/small cell lymphoma. Vick DJ; Byrd JC; Beal CL; Chaffin DJ Vox Sang; 1998; 74(2):122-6. PubMed ID: 9501412 [TBL] [Abstract][Full Text] [Related]
17. The Scripps Clinic experience with cladribine (2-CdA) in the treatment of chronic lymphocytic leukemia. Saven A Semin Hematol; 1996 Jan; 33(1 Suppl 1):28-33. PubMed ID: 8714614 [No Abstract] [Full Text] [Related]
18. Recurrence of autoimmune thrombocytopenia after treatment with fludarabine in a patient with chronic lymphocytic leukemia. Montillo M; Tedeschi A; Leoni P Leuk Lymphoma; 1994 Sep; 15(1-2):187-8. PubMed ID: 7858499 [No Abstract] [Full Text] [Related]